---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-042333"
form_type: "8-K"
ticker: null
cik: "0001413754"
company_name: "MARIZYME, INC."
filed_at: "2023-11-21T23:59:59+00:00"
generated_at: "2026-06-07T22:35:54.588309+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Marizyme completes fifth closing of OID unit private placement, raises $550,000 cash

## Summary
- Issued $647,062 principal amount of 15% OID convertible notes convertible at $0.10 per share to six investors for $550,000 cash.
- Also issued Class E warrants (8.1M shares at $0.10) and Class F warrants (8.1M shares at $0.20) to the same investors.
- Cancelled $150,319 of short-term debt to three consultants by issuing $176,847 principal amount of notes and equivalent warrants.
- Net cash proceeds after 8% placement agent fee to Univest Securities were $506,000; no fee on debt cancellation.
- Notes mature August 20, 2024; warrants exercisable for five years; registration rights waived by all investors.

## SEC filing metadata
- accession: 0001493152-23-042333
- form_type: 8-K
- cik: 0001413754
- company_name: MARIZYME, INC.
- filed_at: 2023-11-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1413754/000149315223042333/0001493152-23-042333-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1413754/000149315223042333/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-042333
- JSON: https://secwatch.observer/filing/0001493152-23-042333.json
- Plain text: https://secwatch.observer/filing/0001493152-23-042333.txt

## Key facts
- Debt Financings
  MARIZYME, INC. incurred convertible notes of aggregate principal amount of $647,062 with nine investors at 15% original issue discount.
  - Instrument: convertible notes
  - Principal: aggregate principal amount of $647,062
  - Counterparty: nine investors
  - Rate: 15% original issue discount
  - Event: incurrence
  source text: the Company issued to these investors 6,470,620 OID Units in aggregate consisting of (i) OID Convertible Notes in the aggregate principal amount of $647,062, convertible into 6,470,620 shares of common stock plus additional shares based on accrued interest at $0.10 per share, subject to adjustment
  evidence_url: https://www.sec.gov/Archives/edgar/data/1413754/000149315223042333/0001493152-23-042333-index.htm
- Material Agreements
  MARIZYME, INC. entered into November 2023 OID Unit Purchase Agreement with each of nine investors valued at up to $10,000,000 (effective 2023-11-20).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: each of nine investors
  - Value: up to $10,000,000
  - Effective: 2023-11-20
  source text: On November 20, 2023, the Company conducted the fifth closing (the “Fifth OID Units Closing”) of a private placement (the “OID Units Private Placement”) of up to $10,000,000 for an aggregate of up to 100,000,000 units (“OID Units”), under a unit purchase agreement between the Company and each of nine investors (the “November 2023 OID Unit Purchase Agreement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1413754/000149315223042333/0001493152-23-042333-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.